MAJESTIC-1 Study -A Subgroup Analysis of High-risk Patients | Luciano Costa, MD | EHA2024

at EHA 2024, Dr. Luciano Costa discusses findings concerning Elranatamab survival rates vs. real-world data.
EHA abstract: library.ehaweb.org/eha/2024/e...
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
Follow HealthTree:
healthtreeformm
healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma